JAK inhibitor Momelotinib mesylate, Purity ≥98%

Synonym: momelotinib Mesylate; CYT387 Mesylate; 1056636-07-7; CYT387 (Mesylate); N-(Cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide; methanesulfonic acid; JAK inhibitor

CAS Number: 1056636-07-7
Compound CID: 78357762

Product Size

1 mg; 5 mg; 10 mg; 25 mg

Price

Datasheet

MSDS

Properties

Description

Momelotinib mesylate is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, and JAK3.

Molecular Weight

510.57

Molecular Formula

C₂₄H₂₆N₆O₅S

Targets

JAK1: 11 nM; JAK2: 18 nM; JAK3: 155 nM

Form

Lyophilized powder

Purity

Identity

Confirmed by NMR/HPLC/MS.

Applications

Momelotinib mesylate can be applied to research inhibition of JAK1 and JAK2 signaling.